Skip to content

Interest Income at other companies

Incyte logo
IncyteINCY
$33.69M+46.9%
Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
$1.78M+240%
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB
$3.05M-35.6%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$779K+13.1%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$8.74M+11.5%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$1.49M+56.0%

Other financials

Income statement

See full
Revenue$2.0M+37.2%
Gross profit$1.6M+68.7%
Operating income-$22.2M-22.7%
Net income-$19.8M-31.4%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$28.7M-5.6%
Total debt$2.0M-20.1%
Total equity$143.6M-0.3%
Total assets$198.7M+0.3%

Cash flow

See full
Operating cash flow-$18.1M-39.0%
CapEx$13.0K-69.8%
Free cash flow-$18.2M-38.6%

Valuation

See full
Market cap$685.75M+337%
Enterprise value$659.07M+410%
P/S82×+73.1×

Profitability

See full
Gross margin76.3%-9.7pp
Operating margin-961.9%+259pp
Net margin-832.6%+132pp
FCF margin-624.9%

Returns & leverage

See full
Return on equity-48.4%-15.4pp
Debt / equity0.0×
Current ratio-1.0×

Where this comes from

Reported directly by Aclaris Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aclaris Therapeutics's interest income?
Aclaris Therapeutics (ACRS) reported interest income of $1.51M in Q1 2026.
How has Aclaris Therapeutics's interest income changed year-over-year?
Aclaris Therapeutics's interest income decreased by 30.1% year-over-year, from $2.17M to $1.51M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.